VT News
Nafia Kuş

Nafia Kuş

Ask VT AI
View News Summary
  • Gilead Sciences reports strong Q2 results, raises full-year guidance, and sees shares rise on expanded insurer coverage for new drug Yeztugo.
  • Lilly's oral weight loss pill trails rivals in efficacy, faces market delay due to tolerability concerns.
  • Veteran Democratic strategist James Carville proposes bold actions for Democrats to 'save democracy' if they win in 2028, including adding states and expanding the Supreme Court.
20 hours
USA flag

United States Politics

Discover the latest news, candidates, 
and key topics of US politics

Latest News
Ask VT AI
View News Summary
  • Gilead Sciences reports strong Q2 results, raises full-year guidance, and sees shares rise on expanded insurer coverage for new drug Yeztugo.
  • Lilly's oral weight loss pill trails rivals in efficacy, faces market delay due to tolerability concerns.
  • Veteran Democratic strategist James Carville proposes bold actions for Democrats to 'save democracy' if they win in 2028, including adding states and expanding the Supreme Court.
20 hours
USA flag

United States Politics

Discover the latest news, candidates, 
and key topics of US politics

Most Reported By
News from Nafia Kuş

Top Topics

Trending in U.S.

World

Sport